Cargando…

Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies

[Image: see text] YopH tyrosine phosphatase, a virulence factor produced by pathogenic species of Yersinia, is an attractive drug target. In this work, three oxidovanadium(IV) complexes were assayed against recombinant YopH and showed strong inhibition of the enzyme in the nanomolar range. Molecular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins, Priscila G. A., Mori, Mattia, Chiaradia-Delatorre, Louise D., Menegatti, Angela C. O., Mascarello, Alessandra, Botta, Bruno, Benítez, Julio, Gambino, Dinorah, Terenzi, Hernán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2015
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641580/ https://www.ncbi.nlm.nih.gov/pubmed/26617957 http://dx.doi.org/10.1021/acsmedchemlett.5b00267

Ejemplares similares

Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH
por: de la Puerta, María Luisa, et al.
Publicado: (2009)

The Yersinia YopE and YopH type III effector proteins enhance bacterial proliferation following contact with eukaryotic cells
por: Bartra, Sara, et al.
Publicado: (2001)

YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia
por: Cantwell, Angelene M, et al.
Publicado: (2010)

Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (PtpB) Inhibitors from Natural Products
por: Mascarello, Alessandra, et al.
Publicado: (2013)

Chicoric acid binds to two sites and decreases the activity of the YopH bacterial virulence factor
por: Kuban-Jankowska, Alicja, et al.
Publicado: (2016)

Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis
por: Kuban-Jankowska, Alicja, et al.
Publicado: (2015)

Aurintricarboxylic acid structure modifications lead to reduction of inhibitory properties against virulence factor YopH and higher cytotoxicity
por: Kuban-Jankowska, Alicja, et al.
Publicado: (2016)

The Amino-Terminal Part of the Needle-Tip Translocator LcrV of Yersinia pseudotuberculosis Is Required for Early Targeting of YopH and In vivo Virulence
por: Ekestubbe, Sofie, et al.
Publicado: (2016)

Yersinia pseudotuberculosis YopH targets SKAP2-dependent and independent signaling pathways to block neutrophil antimicrobial mechanisms during infection
por: Shaban, Lamyaa, et al.
Publicado: (2020)

Heteroleptic Oxidovanadium(V) Complexes with Activity against Infective and Non-Infective Stages of Trypanosoma cruzi
por: Scalese, Gonzalo, et al.
Publicado: (2021)

Di-μ-chlorido-bis[diacetonitrilechloridooxidovanadium(IV)]
por: Dastych, Dalibor, et al.
Publicado: (2011)

cis-Dichloridobis(ethyl methyl sulfide-κS)oxidovanadium(IV)
por: Matsuura, Masatoshi, et al.
Publicado: (2013)

Ligand substitution reactions of a phenolic quinolyl hydrazone; oxidovanadium (IV) complexes
por: Seleem, Hussein S, et al.
Publicado: (2011)

Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme
por: Ferraro, Giarita, et al.
Publicado: (2022)

Structurally Characterized BODIPY-Appended Oxidovanadium(IV) β-Diketonates for Mitochondria-Targeted Photocytotoxicity
por: Bhattacharyya, Utso, et al.
Publicado: (2020)

ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins
por: Ugone, Valeria, et al.
Publicado: (2020)

Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach
por: Cappai, Rosita, et al.
Publicado: (2021)

Suppression of T and B Lymphocyte Activation by a Yersinia pseudotuberculosis Virulence Factor, Yoph
por: Yao, Tony, et al.
Publicado: (1999)

(2,2′-Bipyridine)(pyridine-2,6-dicarboxylato)oxidovanadium(IV) ethanol monosolvate
por: Aghabozorg, Hossein, et al.
Publicado: (2011)

On the Capability of Oxidovanadium(IV) Derivatives to Act as All-Around Catalytic Promoters Since the Prebiotic World
por: Campitelli, Patrizio, et al.
Publicado: (2020)

Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP
por: Sciortino, Giuseppe, et al.
Publicado: (2020)

A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments
por: Naglah, Ahmed M., et al.
Publicado: (2018)

QSAR Modeling, Molecular Docking and Cytotoxic Evaluation for Novel Oxidovanadium(IV) Complexes as Colon Anticancer Agents
por: Alomari, Fatimah Y., et al.
Publicado: (2022)

A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV)
por: Cappai, Rosita, et al.
Publicado: (2022)

Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles
por: Coleman, Matthew A., et al.
Publicado: (2016)

trans-Bis(1,3-diphenylpropane-1,3-dionato)(methanol)oxidovanadium(IV) methanol disolvate
por: Pretorius, Carla, et al.
Publicado: (2012)

Theoretical Investigation by DFT and Molecular Docking of Synthesized Oxidovanadium(IV)-Based Imidazole Drug Complexes as Promising Anticancer Agents
por: Basaleh, Amal S., et al.
Publicado: (2022)

Inflammasome Activation in Response to the Yersinia Type III Secretion System Requires Hyperinjection of Translocon Proteins YopB and YopD
por: Zwack, Erin E., et al.
Publicado: (2015)

YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis
por: Amer, Ayad A. A., et al.
Publicado: (2016)

The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis
por: Joseph, Sabrina S., et al.
Publicado: (2013)

Bis(4,4′-dimethyl-2,2′-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?
por: Francik, Renata, et al.
Publicado: (2017)

Mechanisms of Yersinia YopO kinase substrate specificity
por: Lee, Wei Lin, et al.
Publicado: (2017)

{2,2′-[Ethylenebis(nitrilomethylidyne)]diphenolato-κ(4) O,N,N′,O′}oxidovanadium(IV)
por: Wang, Cheng, et al.
Publicado: (2008)

The Yersinia enterocolitica type three secretion chaperone SycO is integrated into the Yop regulatory network and binds to the Yop secretion protein YscM1
por: Dittmann, Svea, et al.
Publicado: (2007)

Caspase-3 Mediates the Pathogenic Effect of Yersinia pestis YopM in Liver of C57BL/6 Mice and Contributes to YopM's Function in Spleen
por: Ye, Zhan, et al.
Publicado: (2014)

cis-Chloridobis(4,4′-dimethyl-2,2′-bipyridine-κ(2) N,N′)oxidovanadium(IV) chloride ethanol monosolvate monohydrate
por: Shirvan, Sadif A., et al.
Publicado: (2012)

LcrG secretion is not required for blocking of Yops secretion in Yersinia pestis
por: Reina, Laura D, et al.
Publicado: (2008)

Structural Requirements for Yersinia YopJ Inhibition of MAP Kinase Pathways
por: Hao, Yi-Heng, et al.
Publicado: (2008)

Crystal structure of an engineered YopM-InlB hybrid protein
por: Breitsprecher, Dennis, et al.
Publicado: (2014)

Toward a molecular pathogenic pathway for Yersinia pestis YopM
por: Uittenbogaard, Annette M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4ghgi680ujql6ga1t4g8paqtgf